GSK has agreed to acquire Rapt Therapeutics, a US-based biotech whose leading drug combats food allergies, in a deal that ...

Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...

GlaxoSmithKline will purchase Novartis’ 36.5 percent stake in their consumer healthcare joint venture for $13 billion, according to Reuters. Here are four things to know. 1. The $13 billion ...

GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc ...

Emma Walmsley, the CEO who led the U.K. drugmaker GSK through the Covid-19 pandemic and the transformative spinoff of its consumer-health brands, will step down at the end of the year, the company ...

If you are wondering whether GSK shares still offer value at around £18.86, you are not alone. The stock has been attracting ...

In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of ...

GlaxoSmithKline appointed Brian McNamara CEO of the Consumer Healthcare division. 1. Mr. McNamara most recently served as head of Europe and the Americas at GSK Consumer Healthcare. 2. Prior to ...

Anyone expecting a new chief executive of GlaxoSmithKline (NYSE:GSK) to take a fresh look at spinning off its consumer health arm should think again. The often-discussed move was always firmly ...